Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Common Equity (2016 - 2024)

Historic Common Equity for Zepp Health (ZEPP) over the last 9 years, with Q4 2024 value amounting to $252.7 million.

  • Zepp Health's Common Equity fell 2734.46% to $252.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $252.7 million, marking a year-over-year decrease of 2734.46%. This contributed to the annual value of $252.7 million for FY2024, which is 2835.53% down from last year.
  • According to the latest figures from Q4 2024, Zepp Health's Common Equity is $252.7 million, which was down 2734.46% from $347.8 million recorded in Q4 2023.
  • In the past 5 years, Zepp Health's Common Equity registered a high of $458.8 million during Q4 2021, and its lowest value of $252.7 million during Q4 2024.
  • For the 5-year period, Zepp Health's Common Equity averaged around $369.8 million, with its median value being $377.5 million (2022).
  • In the last 5 years, Zepp Health's Common Equity surged by 1611.27% in 2020 and then plummeted by 2734.46% in 2024.
  • Quarter analysis of 5 years shows Zepp Health's Common Equity stood at $412.0 million in 2020, then grew by 11.37% to $458.8 million in 2021, then fell by 17.72% to $377.5 million in 2022, then fell by 7.86% to $347.8 million in 2023, then dropped by 27.34% to $252.7 million in 2024.
  • Its last three reported values are $252.7 million in Q4 2024, $347.8 million for Q4 2023, and $377.5 million during Q4 2022.